www.foxnews.com

www.foxnews.com
Share

www.foxnews.com

 •  January 23

LONDON – Biotech deal activity exploded on Monday with French drugmaker Sanofi and U.S.-based Celgene spending a combined total of more than $20 billion to add new products for hemophilia and cancer to their medicine cabinets. The acquisitions will fuel expectations for a busy year of mergers and acquisitions (M&A) as large drugmakers snap up...

www.foxnews.com

 •  December 1, 2017

One of the largest U.S. patient assistance charities may close after the federal government revoked its authorization, citing findings that the group, mainly funded by pharmaceutical companies, enabled drugmakers to influence prescriptions. The Department of Health and Human Services' Office of Inspector General notified Caring Voice Coalition in a...

www.foxnews.com

 •  November 22, 2017

NEW YORK – The U.S. Food and Drug Administration on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed at easing the side effects for long-term patients who are on the standard treatment involving three or more drugs. The treatment, called Juluca, is a fixed-dose tablet that combines two previously approved...

www.foxnews.com

 •  November 2, 2017

Indivior Plc's experimental drug to treat opioid addiction is effective and should be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Tuesday. The panel voted 18-1 that the injectable drug, known as RBP-6000, could benefit addicts and the lower of two doses studied has an acceptable safety profile. The FDA...

www.foxnews.com

 •  October 26, 2017

Tesaro Inc said on Wednesday that the U.S. Food and Drug Administration approved an intravenous version of its drug to treat chemotherapy-induced nausea and vomiting in adults. The intravenous version of the already-approved drug, Varubi, will be used in combination with other agents to prevent delayed nausea and vomiting associated with some forms...

www.foxnews.com

 •  September 29, 2017

NEW YORK – Makers of fast-acting opioids will have to fund voluntary training for healthcare professionals who prescribe the drugs, including education on safe prescribing practices and non-opioid alternatives, the U.S. Food and Drug Administration (FDA) said on Thursday. The FDA sent letters to 74 manufacturers of immediate-release opioids,...

www.foxnews.com

 •  September 11, 2017

The last time there was a new drug to fight amyotrophic lateral sclerosis (ALS) the shows “ER” and “Seinfeld” were battling it out for the top spot on television. That 22-year medical drought ended about three weeks ago. In August, the drug Radicava became available in the United States to treat ALS, also known as Lou Gehrig’s disease. Radicava was...

www.foxnews.com

 •  August 29, 2017

The active ingredient in the drug ecstasy passed an important hurdle on the path to becoming a prescription drug for treating post-traumatic stress disorder. The ingredient, MDMA, was granted "Breakthrough Therapy Designation" status by the U.S. Food and Drug Administration (FDA), according to a statement released Aug. 26 by the Multidisciplinary...

www.foxnews.com

 •  June 29, 2017

An experimental drug reduces eye damage in people with a common form of vision loss for which there is currently no available treatment, a new study finds. The new research sought to treat age-related macular degeneration (AMD) , the leading cause of vision loss in industrialized countries, according to the World Health Organization. The disease...

www.foxnews.com

 •  June 21, 2017

The United States is in the middle of an opioid crisis, so it's easy to assume that all opioids can be equally detrimental to people's health. But now, the Food and Drug Administration says one in particular is especially contributing to the opioid epidemic. The FDA has asked Irish pharmaceutical company Endo International to take one of its pain...